Invention Application
- Patent Title: Compounds for the Treatment of Kinase-Dependent Disorders
-
Application No.: US17425661Application Date: 2020-01-24
-
Publication No.: US20220089541A1Publication Date: 2022-03-24
- Inventor: Lynne Canne Bannen , Faming Jiang , Kin Tso , Xu Wei
- Applicant: Exelixis, Inc.
- Applicant Address: US CA Alameda
- Assignee: Exelixis, Inc.
- Current Assignee: Exelixis, Inc.
- Current Assignee Address: US CA Alameda
- International Application: PCT/US2020/014979 WO 20200124
- Main IPC: C07D215/22
- IPC: C07D215/22 ; C07D215/48 ; C07D401/12 ; C07D471/04 ; A61P35/00
Abstract:
The present invention relates to compounds that modulate cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion, by modulating protein kinase enzymatic activity, and compositions thereof, and methods of using such compounds.
Information query
